SCHEMBL13947209

SCHEMBL13947209

Cc1ccc(C(=O)NCc2ccc(C)nc2Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.52
▸ HTT P42858 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ TP53 P04637 2/20 0.46
▸ POLB P06746 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NLRP1 Q9C000 1/20 0.45
▸ MMP2 P08253 1/20 0.45
▸ STAT3 P40763 1/20 0.45
▸ MMP13 P45452 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13947406 0.84 MAPT (0.50) MAPTHTTTDP1ALDH1A1KDM4E
SCHEMBL13947097 0.80 MAPT (0.46) MAPTHTTTDP1ALDH1A1KDM4E
SCHEMBL13947075 0.78 TP53 (0.47) MAPTHTTTDP1ALDH1A1KDM4E
SCHEMBL5642926 0.75 LMNA (0.75) MAPTHTTALDH1A1TP53LMNA
SCHEMBL9792253 0.75 NPC1 (0.56) MAPTHTTTDP1ALDH1A1TP53
SCHEMBL13947384 0.75 SMN1; SMN2 (0.73) MAPTALDH1A1KDM4ETP53POLB
SCHEMBL5645497 0.73 ROCK2 (0.58) LMNAMAPK1NLRP1EPHX2NR1H4
SCHEMBL13932522 0.71 ALDH1A1 (0.78) MAPTHTTTDP1ALDH1A1KDM4E
SCHEMBL25872270 0.71 MEN1 (0.72) MAPTHTTTDP1ALDH1A1KDM4E
SCHEMBL13947380 0.71 MEN1 (0.72) MAPTHTTTDP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases MAIER UDO 2009-01-29 — — US disclosed
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043055-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 MAPT 4256/4885HTT 616/4885TDP1 3846/4885
US-20090029990-A1 Dihydropteridinones in the treatment of respiratory diseases QDPR, DHPS, NDUFS6 MAPT 4256/4885HTT 616/4885TDP1 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback